S
Shannon L. Carpenter
Researcher at Children's Mercy Hospital
Publications - 67
Citations - 1648
Shannon L. Carpenter is an academic researcher from Children's Mercy Hospital. The author has contributed to research in topics: Child abuse & Medicine. The author has an hindex of 15, co-authored 58 publications receiving 1276 citations. Previous affiliations of Shannon L. Carpenter include Duke University & University of Missouri–Kansas City.
Papers
More filters
Journal ArticleDOI
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings
Laurel K. Willig,Laurel K. Willig,Josh E Petrikin,Josh E Petrikin,Laurie D. Smith,Laurie D. Smith,Carol J Saunders,Carol J Saunders,Isabelle Thiffault,Isabelle Thiffault,Neil A. Miller,Sarah E Soden,Julie A. Cakici,Suzanne Herd,Greyson P Twist,Aaron Noll,Mitchell Creed,Patria M Alba,Patria M Alba,Shannon L. Carpenter,Shannon L. Carpenter,Mark A. Clements,Mark A. Clements,Ryan T. Fischer,Ryan T. Fischer,J Allyson Hays,J Allyson Hays,Howard W. Kilbride,Howard W. Kilbride,Ryan McDonough,Jamie L Rosterman,Sarah L Tsai,Sarah L Tsai,Lee Zellmer,Emily G. Farrow,Emily G. Farrow,Stephen F. Kingsmore +36 more
TL;DR: A substantial need for rapid genomic diagnoses to be allied with a novel framework for precision medicine for infants in NICU and PICU who are diagnosed with genetic diseases to improve outcomes is indicated.
Journal ArticleDOI
The Role of Inflammation in Venous Thromboembolism.
TL;DR: Identification of biomarkers to evaluate VTE risk could be of great use to the clinician caring for a patient with inflammatory disease to guide decisions regarding the risk:benefit ratio of various types of potential thromboprophylaxis strategies, or suggest a role for anti-inflammatory therapy.
Journal ArticleDOI
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors.
Cindy A. Leissinger,Alessandro Gringeri,Bülent Antmen,Erik Berntorp,Chiara Biasoli,Shannon L. Carpenter,Paolo Cortesi,Hyejin Jo,Kaan Kavakli,Riitta Lassila,Massimo Morfini,Claude Negrier,Angiola Rocino,Wolfgang Schramm,Margit Serban,Marusia Valentina Uscatescu,Jerzy Windyga,Bulent Zulfikar,Lorenzo G. Mantovani +18 more
TL;DR: AICC prophylaxis at the dosage evaluated significantly and safely decreased the frequency of joint and other bleeding events in patients with severe hemophilia A and factor VIII inhibitors.
Journal ArticleDOI
Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
TL;DR: The history of the discovery of α2‐antiplasmin, the understanding of its genetics and function, and the current knowledge of its congenital deficiency are reviewed.
Journal ArticleDOI
AKI in Children Hospitalized with Nephrotic Syndrome
Michelle N. Rheault,Lei Zhang,David T. Selewski,Mahmoud Kallash,Cheryl L. Tran,Meredith Seamon,Chryso Katsoufis,Isa F. Ashoor,Joel Hernandez,Katarina Supe-Markovina,Cynthia D'Alessandri-Silva,Nilka DeJesus-Gonzalez,Tetyana L. Vasylyeva,Cassandra Formeck,Christopher Woll,Rasheed Gbadegesin,Pavel Geier,Prasad Devarajan,Shannon L. Carpenter,Bryce A. Kerlin,William E. Smoyer +20 more
TL;DR: AKI is common in children hospitalized with nephrotic syndrome and should be deemed the third major complication of nephrotsic syndrome in children in addition to infection and venous thromboembolism.